88 related articles for article (PubMed ID: 51128)
1. [Products of degradation of fibrinogen in surgical patients].
Golovastova GI; Guseĭnov ChS
Lab Delo; 1975; (6):368-71. PubMed ID: 51128
[No Abstract] [Full Text] [Related]
2. Normal fibronectin levels after surgical treatment of portal hypertension in liver cirrhosis.
De Angelis V; Zambon M; Toffolo L; Voltan GP; Orazi BM; Santarossa L; Donada C; Zuin R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):89-93. PubMed ID: 1695189
[TBL] [Abstract][Full Text] [Related]
3. [Circulation in liver cirrhosis patients and the principles for correcting portal hypertension].
Patsiora MD; Ershov IuA
Khirurgiia (Mosk); 1973 May; 49(5):72-9. PubMed ID: 4795477
[No Abstract] [Full Text] [Related]
4. [Significance of antithrombin III and fibrin degradation products for the prognosis and diagnosis of postoperative thromboses].
Rjabzew WG; Bokarew IN; Gordejew PS; Butorow WN
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):171-5. PubMed ID: 6177600
[No Abstract] [Full Text] [Related]
5. [The surgical treatment of portal hypertension].
Tadzhiev KT; Usmanov NU; Smirnova LF
Khirurgiia (Mosk); 1965 Nov; 41(11):43-7. PubMed ID: 5879083
[No Abstract] [Full Text] [Related]
6. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
Klingemann HG; Brunswig D; Liehr H
Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
[TBL] [Abstract][Full Text] [Related]
7. [Intravascular coagulation in lung cancer patients in the postoperative period].
Madzhuga AV; Varlamova OA; Pavlova ZV
Anesteziol Reanimatol; 1978; (1):67-70. PubMed ID: 637357
[No Abstract] [Full Text] [Related]
8. Haemostatic activation before and after surgery in patients with and without gastric malignancy.
Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C; Nieuwenhuizen W
Thromb Haemost; 1994 Jun; 71(6):713-8. PubMed ID: 7974337
[TBL] [Abstract][Full Text] [Related]
9. [Comparative evaluation of indices of activity of the blood anticoagulation system in patients with cancer of the lung, stomach and breast during surgical treatment].
Bergut FA
Lab Delo; 1969; 1():54-6. PubMed ID: 4185364
[No Abstract] [Full Text] [Related]
10. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Heene DL; Genth K
Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
[No Abstract] [Full Text] [Related]
11. Regulation of fibrinogen synthesis in portal hypertension.
Grün M; Liehr H; Brunswig D; Thiel H
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):292-305. PubMed ID: 4450188
[No Abstract] [Full Text] [Related]
12. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
Rocha E; López Borrasca A
Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
[No Abstract] [Full Text] [Related]
13. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
J Med; 1984; 15(2):149-60. PubMed ID: 6096471
[TBL] [Abstract][Full Text] [Related]
14. [The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)].
Soria J; Soria C; de Rodriguez S; Horellou MH; Samama M; Bilski-Pasquier G
Nouv Presse Med; 1977 Dec; 6(43):4045-8. PubMed ID: 600751
[TBL] [Abstract][Full Text] [Related]
15. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
[TBL] [Abstract][Full Text] [Related]
16. [Serum levels of fibrinogen degradation products in patients with hepatic cirrhosis].
Cristani A; Cioni G; Minetto G; Di Pancrazio L; Anderlini D; Grandi S; Vezzelli C; Zirilli E; Zeneroli ML; Ventura E
Recenti Prog Med; 1987 Oct; 78(10):431-3. PubMed ID: 3432720
[No Abstract] [Full Text] [Related]
17. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon.
Wojtukiewicz MZ; Zacharski LR; Moritz TE; Hur K; Edwards RL; Rickles FR
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):429-37. PubMed ID: 1330024
[TBL] [Abstract][Full Text] [Related]
18. Coagulopathy in liver disease: the whole is greater than the sum of its parts.
Hodge A; Crispin P
J Gastroenterol Hepatol; 2010 Jan; 25(1):1-2. PubMed ID: 20136967
[No Abstract] [Full Text] [Related]
19. Fibrin-fibrinogen degradation products in hepatic cirrhosis.
Bulajić M; Kovacević N; Lalić M; Rolović Z
Acta Med Iugosl; 1977; 31(4):333-8. PubMed ID: 596236
[No Abstract] [Full Text] [Related]
20. [Detection of fibrinolytic split products in patient collections with disordered hemostasis. I. In pathologically verified lung cancer. II. In thrombotic/embolic occurrences].
Bube FW; Egenolf F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):447-54. PubMed ID: 6169607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
